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INTRODUCTION
Malignant otitis externa (MOE) is a 
severe, invasive and necrotizing infectious 
disease that starts in the external auditory 
meatus (EAM) and may progress to the 
parotid region, mastoid, middle ear and 
skull base1.
It affects mainly the diabetic, the 
elderly and immunosuppressed patients. 
Main etiological agent: P. aeruginosa.
Symptoms: Otalgia, mal-odorous 
otorrhea and local edema
Diagnosis is carried out through 
anamnesis, clinical exam, finding the germ 
and complementary exams. Temporal 
bone CT Scans allows for the identifica-
tion of MOE erosions and the MRI defines 
its expansion to the skull base. Although 
non-specific, ESR (erythrocyte sedimen-
tation rate) is a parameter that measures 
MOE’s evolution2,3.
Differential diagnosis: benign ne-
oplasia of the EAM, malignant neoplasia 
of the EAM and cholesteatoma4.
Treatment: IV ciprofloxacin and 
continue with it orally until HSS norma-
lization.
CASE PRESENTATION
JB, 53 years old, with intense left 
side otalgia, irradiating to the temporal 
region and half of his face. 
It’s been developing for one month, 
after swimming in the ocean, treated with 
ear drops, without improvement. Patient 
reports never having ear problems or D. 
mellitus.
Otoscopy: EAM edema, purulent 
otorrhea and tenderness. Tympanic mem-
brane was not visible. Under the assump-
tion of an external otitis media, we medi-
cated the patient with IM betamethasone, 
amoxicillin 1.5g/day per os and topical 
ciprofloxacin.
The patient did not show significant 
improvement. We then requested a CT 
scan and prescribed ciprofloxacin per os 
1.5g/day and topical drops for maintenance 
treatment.
CT scan (figure 1) showed a hyper-
dense lesion occluding all the EAM, ero-
sion of its walls and the petrous bone, 
with inflammatory mastoiditis. Differential 
diagnosis did not rule out a neoplastic le-
sion; however the latter was ruled out by 
MRI. Glucose levels, CBC and ESR within 
normal ranges. 
Considering a diagnosis of MOE, 
we chose to use 750mg of ciprofloxacin 
BID per os. 
After one month without com-
plaints, otoscopy showed a significant 
improvement. 
Tonal audiometry: mixed hearing 
loss, more intense in the higher frequencies 
with a 10 to 25dBHL bone-air gap.
Tympanometry in -250 dcPa. No 
stapedial reflexes.
DISCUSSION
D. Mellitus may represent a predis-
posing factor for MOE1,2,5,6; however all 
tests were normal. The germ was not found 
because of previous treatment. MOE diag-
nosis was based on the anamnesis and the 
patient’s response to treatment. We have to 
bear in mind that the patient had not had 
any prior ear infection. The inefficiency 
of the previous treatment allowed us to 
consider the possibility of MOE.
CT scan findings (Figure 1) have 
corroborated that information.  Please 
notice that Chaussé’s spur, epitympanum 
and the incus-malleus joint are intact. The 
mastoid disease is a reactional inflamma-
tory process. MRI ruled out malignant 
neoplasia or cholesteatoma. The disease 
progression and the image findings indu-
bitably led us to conclude for diagnosis 
of MOE in a patient lacking conventional 
predisposing factors. 
Oral ciprofloxacin or ceftazidi-
me and IV cefoperazone, associated to 
ciprofloxacin per os represent the drug 
treatment of choice. In the present case, 
we chose to use ciprofloxacin per os for 2 
weeks3, with both clinical and otoscopic 
improvement. Considering the disease’s 
course and the possibility of sequela and 
fatal complications, we stress the need to 
be attentive towards this condition, and 
not underestimate any external otitis, 
always suspect of MOE, especially in 
cases of unexpected developments regar-
ding the prescribed treatment.
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Figure 1. Temporal bone CT Scan - Left Ear.
